A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age
Clinical trial NCT05995275 · COMPLETED
Trial details
- NCT number
- NCT05995275
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2025-07-08
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.